Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial

Lancet Respiratory Medicine,The - Tập 10 - Trang 1119-1128 - 2022
Holly R Keir1, Merete B Long1, Hani Abo-Leyah1, Yan Hui Giam1, Thenmalar Vadiveloo2, Thomas Pembridge1, Rebecca C Hull3, Lilia Delgado1, Margaret Band1, Fiona McLaren-Neil1, Simon Adamson1, Eva Lahnsteiner1, Amy Gilmour1, Chloe Hughes1, Benjamin JM New1, David Connell1, Rebecca Dowey3, Helena Turton3, Hollian Richardson1, Diane Cassidy1
1Molecular and Clinical Medicine, University of Dundee, Dundee, UK
2Health Services Research Unit, University of Aberdeen, Aberdeen, UK
3Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Lancet Respiratory Medicine,The

Tập 10

1119-1128

Thông tin tác giả